Your browser doesn't support javascript.
loading
Nonclinical Safety Assessment of FHTR2163, An Antigen-Binding Fragment Against HTRA1 for the Treatment of Geographic Atrophy.
Dere, Edward; Crowell, Susan; Maia, Mauricio; Schuetz, Chris; Lai, Phillip; Bantseev, Vladimir; Booler, Helen.
Affiliation
  • Dere E; Department of Safety Assessment, 7412Genentech Inc., South San Francisco, CA, USA.
  • Crowell S; Department of Preclinical and Translational Pharmacokinetics and Pharmacodynamics, 7412Genentech Inc., South San Francisco, CA, USA.
  • Maia M; Department of Bioanalytical Sciences, 7412Genentech Inc., South San Francisco, CA, USA.
  • Schuetz C; Department of Safety Assessment, 7412Genentech Inc., South San Francisco, CA, USA.
  • Lai P; Department of Early Clinical Development OMNI, 7412Genentech Inc., South San Francisco, CA, USA.
  • Bantseev V; Department of Safety Assessment, 7412Genentech Inc., South San Francisco, CA, USA.
  • Booler H; Department of Safety Assessment, 7412Genentech Inc., South San Francisco, CA, USA.
Toxicol Pathol ; 49(3): 610-620, 2021 04.
Article in En | MEDLINE | ID: mdl-33297886
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Geographic Atrophy Limits: Animals / Humans Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Geographic Atrophy Limits: Animals / Humans Language: En Year: 2021 Type: Article